President of DiaPrep System Inc., Doctor of Medicine Mykhailo Favorov described the process of creation of the Ukrainian vaccine against Covid-19 as he is one of the developers as TSN reported.
“Our (Ukrainian) vaccine was initially designed not as the vaccine – it is a prototype of a prototype. Initially, it was designed as the traditional vaccine. You know that all newborns in Ukraine get the vaccination against hepatitis B. Our vaccine is made on the same principle. We created a protein – a recombinant protein (produced in E.coli, a rod-shaped bacteria), which is present in the normal human body that is in symbiosis with us. Possibly, I believe, it might be transferred into another carrier that will be considered after the approach to the production (of the vaccine, - 112.international). The making of antibodies will be recommended for this protein,” Favorov said.
He also noted that it is impossible to get the antibodies for usual proteins.
The Ukrainian vaccine that is planned to try on people soon was criticized. Particularly, Military Epidemiologist Serhiy Kravchenko noted that the President’s Office states about the creation of the vaccine due to ‘the race for political hype’.
Later, Favorov was called a speculator and he stated about the possible stop of the clinical trial of the vaccine due to such a reaction to his development.
“The vaccine was created at our own expense. The state has not allocated even a penny. It is stated what can be made of it if serious contributions are made. I am not sure that the vaccine will be developed with such an attitude. In six months, we could have a vaccine. But if you do not like it, let’s not do it. I came at my own expense – nobody paid me,” Favorov said.
Earlier, President of Ukraine Volodymyr Zelensky stated that he was ready to test the Ukrainian vaccine from coronavirus if it passes the stage of clinical tests.
Besides, Minister of Health Maksym Stepanov stated that the Ukrainian vaccine against coronavirus, the production of which will take up to a year, will cost more than $ 5 million.